Protective effect of verapamil on multiple hepatotoxic factors-induced liver fibrosis in rats

Pharmacological Research

Volumn 55, Issue 4, 2007, Pages 280-286

  Xu, Dan ^a   Wu, Yong ^a   Liao, Zhang Xiu ^a   Wang, Hui ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Smooth muscle actin; Hepatic stellate cells; Liver fibrosis; Transforming growth factor 1; Verapamil

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; ALPHA SMOOTH MUSCLE ACTIN; CARBON TETRACHLORIDE; CHOLESTEROL; COLLAGEN; HYDROXYPROLINE; MALONALDEHYDE; TRANSFORMING GROWTH FACTOR BETA1; VERAPAMIL;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL PROTECTION; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; DRUG EFFICACY; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER CELL; LIVER FIBROSIS; LIVER PROTECTION; LIVER TOXICITY; MALE; NONHUMAN; PARAMETER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STELLATE CELL; WISTAR RAT;

ACTINS; ALANINE TRANSAMINASE; ANIMALS; CARBON TETRACHLORIDE; COLLAGEN; DIETARY FATS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HYDROXYPROLINE; LIVER; LIVER CIRRHOSIS; MALE; MALONDIALDEHYDE; NECROSIS; PROTECTIVE AGENTS; RATS; RATS, WISTAR; TRANSFORMING GROWTH FACTOR BETA1; VERAPAMIL;

EID: 34047125469     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2006.12.003     Document Type: Article

References (26)

1. Bataller R., and Brenner D.A. Liver fibrosis. J Clin Invest 115 (2005) 209-218
2. Reynaert H., Thompson M.G., Thomas T., and Geerts A. Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension. Gut 50 (2002) 571-581
3. Maier K.P. Drug therapy in chronic liver disease. Schweiz Rundsch Med Prax 94 (2005) 1907-1912
4. Gould B.A., Mann S., Kieso H., Subramanian V.B., and Raftery E.B. The 24-h ambulatory blood pressure profile with verapamil. Circulation 65 (1982) 22-27
5. Reichen J., and Le M. Verapamil favorably Influences hepatic microvascular exchange and function in rats with cirrhosis of the Liver. J Clin Invest 78 (1986) 448-455
6. Reichen J., Hirlinger A., Ha H.R., and Sagesser S. Chronic verapamil administration lowers portal pressure and improved hepatic function in rats with liver cirrhosis. J Hepatol 3 (1986) 49-58
7. Guo C.Y., Wu J.Y., Wu Y.B., Zhong M.Z., and Lu H.M. Effects of endothelin-1 on hepatic stellate cell proliferation, collagen synthesis and secretion, intracellular free calcium concentration. World J Gastroenterol 10 (2004) 2697-2700
8. Wang H., Liao Z.X., Chen M., and Hu X.L. Effects of hepatic fibrosis on ofloxacin pharmacokinetics in rats. Pharmacol Res 53 (2006) 28-34
9. Mihara M., and Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 86 (1978) 271-278
10. 2+ currents in cardiac myocytes: old story, new insights. Prog Biophys Mol Biol 91 (2006) 1-82
11. Deitmer J.W., Ivens I., and Pernberg J. Changes in voltage-dependent calcium currents during the cell cycle of the ciliate Stylonychia. Exp Cell Res 162 (1986) 549-554
12. Xiao Y.H., Liu D.W., and Li Q. Effects of drug serum of anti-fibrosis I herbal compound on calcium in hepatic stellate cell and its molecular mechanism. World J Gastroenterol 11 (2005) 1515-1520
13. Gorbig M.N., Gines P., Bataller R., Nicolas J.M., Garcia-Ramallo E., Cejudo P., et al. Human hepatic stellate cells secrete adrenomedullin: potential autocrine factor in the regulation of cell contractility. J Hepatol 34 (2001) 222-229
14. Xidakis C., Ljumovic D., Manousou P., Notas G., Valatas V., Kolios G., et al. Production of pro- and anti-fibrotic agents by rat Kupffer cells; the effect of octreotide. Dig Dis Sci 50 (2005) 935-941
15. Breitkopf K., Sawitza I., and Gressner A.M. Characterization of intracellular pathways leading to coinduction of thrombospondin-1 and TGF-beta1 expression in rat hepatic stellate cells. Growth Factors 23 (2005) 77-85
16. Oide H., and Thurman R.G. Hepatic ito cells contain calcium channels: increases with transforming growth factor-beta 1. Hepatology 20 (1994) 1009-1014
17. Hijilka T., Rosenberg R.L., Lemasters J.J., and Thurman R.G. Kuffer cells contain valtage-dependent calcium channels. Mol Pharmacol 41 (1992) 435-440
18. Bataller R., Gasull X., Gines P., Hellemans K., Gorbig M.N., Nicolas J.M., et al. In vitro and in vivo activation of rat hepatic stellate cells results in de novo expression of L-type voltage-operated calcium channels. Hepatology 33 (2001) 956-962
19. 2+ exchanger emerges in hepatic stellate cells after activation in association with liver fibrosis. Proc Natl Acad Sci USA 95 (1998) 5389-5394
20. Yee Jr. H.F. Ca2+ and rho signaling pathways: two paths to hepatic stellate cell contraction. Hepatology 4 (2001) 1007-1008
21. Gressner A.M., Weiskirchen R., Breitkopf K., and Dooley S. Roles of TGF-beta in liver fibrosis. Front Biosci 7 (2002) 793-807
22. (2+)-dependent and independent mitochondrial damage in hepatocellular injury. Cell Calcium 12 (1991) 335-341
23. 2+ channels. J Physiol 535 (2001) 663-677
24. Basu S. Carbon tetrachloride-induced lipid peroxidation: eicosanoid formation and their regulation by antioxidant nutrients. Toxicology 189 (2003) 113-127
25. Comporti M., Arezzini B., Signorini C., Sgherri C., Monaco B., and Gardi C. F2-isoprostanes stimulate collagen synthesis in activated hepatic stellate cells: a link with liver fibrosis?. Lab Invest 85 (2005) 1381-1391
26. Drewa G., Krzyzynska-Malinowska E., Wozniak A., Protas-Drozd F., Mila-Kierzenkowska C., Rozwodowska M., et al. Activity of superoxide dismutase and catalase and the level of lipid peroxidation products reactive with TBA in patients with psoriasis. Med Sci Monit 8 (2002) 338-343